Making CAR T-cell therapies more affordable.
作者信息
Senior Kathryn
出版信息
Lancet. 2025 Jan 18;405(10474):187-188. doi: 10.1016/S0140-6736(24)02719-3. Epub 2024 Dec 13.
Abstract
摘要
相似文献
1
Making CAR T-cell therapies more affordable.让嵌合抗原受体T细胞疗法更具可及性。
Lancet. 2025 Jan 18;405(10474):187-188. doi: 10.1016/S0140-6736(24)02719-3. Epub 2024 Dec 13.
2
Horses for Courses in the Era of CARs: Advancing CAR T and CAR NK Cell Therapies.嵌合抗原受体（CAR）时代的因材施教：推进CAR-T和CAR-NK细胞疗法
J Pers Med. 2021 Nov 11;11(11):1182. doi: 10.3390/jpm11111182.
3
Better by design: What to expect from novel CAR-engineered cell therapies?设计更优：新型CAR工程细胞疗法的前景如何？
Biotechnol Adv. 2022 Sep;58:107917. doi: 10.1016/j.biotechadv.2022.107917. Epub 2022 Feb 9.
4
Advancements in CAR-NK therapy: lessons to be learned from CAR-T therapy.嵌合抗原受体自然杀伤（CAR-NK）细胞疗法的进展：从嵌合抗原受体 T（CAR-T）细胞疗法中吸取的经验教训。
Front Immunol. 2023 May 2;14:1166038. doi: 10.3389/fimmu.2023.1166038. eCollection 2023.
5
Development of a Novel Anti-CD19 Chimeric Antigen Receptor: A Paradigm for an Affordable CAR T Cell Production at Academic Institutions.一种新型抗CD19嵌合抗原受体的开发：学术机构中经济实惠的CAR-T细胞生产范例
Mol Ther Methods Clin Dev. 2018 Dec 6;12:134-144. doi: 10.1016/j.omtm.2018.11.010. eCollection 2019 Mar 15.
6
Mitigation and Management of Common Toxicities Associated with the Administration of CAR-T Therapies in Oncology Patients.肿瘤患者接受CAR-T疗法相关常见毒性的缓解与管理
Drug Saf. 2025 Mar 19. doi: 10.1007/s40264-025-01538-5.
7
Minicircles for CAR T Cell Production by Sleeping Beauty Transposition: A Technological Overview.基于睡美人转座子的 CAR T 细胞生产用微小环：技术概述。
Methods Mol Biol. 2022;2521:25-39. doi: 10.1007/978-1-0716-2441-8_2.
8
In Synergy: Optimizing CAR T Development and Personalizing Patient Care Using Single-Cell Technologies.协同作用：利用单细胞技术优化嵌合抗原受体T细胞疗法的开发并实现患者护理个性化
Cancer Discov. 2023 Jul 7;13(7):1546-1555. doi: 10.1158/2159-8290.CD-23-0010.
9
Availability and financing of CAR-T cell therapies: A cross-country comparative analysis.嵌合抗原受体 T 细胞疗法的可及性和融资：跨国比较分析。
Health Policy. 2024 Nov;149:105153. doi: 10.1016/j.healthpol.2024.105153. Epub 2024 Sep 12.
10
Expanding the horizon of transient CAR T therapeutics using virus-free technology.利用无病毒技术拓展嵌合抗原受体 T 细胞治疗的视野。
Biotechnol Adv. 2024 May-Jun;72:108350. doi: 10.1016/j.biotechadv.2024.108350. Epub 2024 Mar 26.
引用本文的文献
1
Novel strategies to overcome tumor immunotherapy resistance using CAR NK cells.使用嵌合抗原受体自然杀伤细胞（CAR NK细胞）克服肿瘤免疫治疗耐药性的新策略。
Front Immunol. 2025 May 29;16:1550652. doi: 10.3389/fimmu.2025.1550652. eCollection 2025.
2
From molecular design to clinical translation: dual-targeted CAR-T strategies in cancer immunotherapy.从分子设计到临床转化：癌症免疫治疗中的双靶点嵌合抗原受体T细胞策略
Int J Biol Sci. 2025 Mar 31;21(6):2676-2691. doi: 10.7150/ijbs.108036. eCollection 2025.
Zotero 插件